Clinical Trial Update: Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib [Phase 4]

View source ↗

Summary

This is a multicenter, Phase 4 open-label trial of nilotinib in adult patients with Philadelphia chromosome–positive chronic myeloid leukemia who are intolerant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Leukemia, Chronic Myeloid | Phase 4 | Status: UNKNOWN